Precision BioSciences
DTIL
56 hedge funds and large institutions have $25.7M invested in Precision BioSciences in 2025 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
38% more capital invested
Capital invested by funds: $18.6M → $25.7M (+$7.03M)
8% more funds holding
Funds holding: 52 → 56 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.58% less ownership
Funds ownership: 40.02% → 39.45% (-0.58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$555K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$418K |
| 3 |
Two Sigma Investments
New York
|
+$320K |
| 4 |
Two Sigma Advisers
New York
|
+$249K |
| 5 |
BlackRock
New York
|
+$197K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$510K |
| 2 |
Corient Private Wealth
Miami,
Florida
|
-$437K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$201K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$130K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$103K |
DTIL Hedge Fund Activity: Q3 2025 in Review
56 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q3 2025, worth a combined $25.7M — up 38% from $18.6M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new DTIL positions and 7 closed out — a net gain of 4 holders — while 14 added to existing stakes and 10 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $555K. The largest seller was Acadian Asset Management, cutting an estimated $510K.
- 56 institutional investors held Precision BioSciences (DTIL) as of Q3 2025, up from 52 in Q2 2025.
- Funds reported $25.7M of Precision BioSciences stock for Q3 2025, up 38% quarter-over-quarter.
- 11 funds opened new Precision BioSciences positions in Q3 2025 and 7 closed out, a net change of +4 holders.
- The largest Precision BioSciences buyer in Q3 2025 was Renaissance Technologies, an estimated $555K added.
- The largest Precision BioSciences seller in Q3 2025 was Acadian Asset Management, an estimated $510K sold.
Based on aggregated 13F filings for Q3 2025.